Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2010 by St George's Healthcare NHS Trust.
Recruitment status was:  Not yet recruiting
Information provided by:
St George's Healthcare NHS Trust Identifier:
First received: June 30, 2010
Last updated: NA
Last verified: June 2010
History: No changes posted
There is a rare condition causing scarring of the lungs termed interstitial lung disease. This comprises a group of conditions which can be divided into separate diseases. The aim of this study is compare a group of patients (the cases) with 2 types of this disease (fibrotic non-specific interstitial pneumonia (NSIP) and idiopathic pulmonary fibrosis (IPF)) with patients without the disease. The study will look at the 2 groups and their exposures to factors such as medications, smoking, previous jobs, previous medical problems and specifically heart disease and any operations or procedures involving the heart. There have been previous studies showing a link between heart disease and scarring of the lungs. This study will look at whether this association is stronger in one or the other type of lung scarring diseases.

Idiopathic Pulmonary Fibrosis
Interstitial Pneumonia

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Case-Control Study of Fibrotic Interstitial Lung Disease and it's Association With Cardiac Disease or Cardiac Intervention.

Resource links provided by NLM:

Further study details as provided by St George's Healthcare NHS Trust:

Estimated Enrollment: 360
Study Start Date: July 2010
Estimated Study Completion Date: April 2011
Estimated Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Cases - patients with IPF or UIP. Controls - hospital clinic attenders.

Inclusion Criteria:

  • idiopathic fibrotic lung disease

Exclusion Criteria:

  • non idiopathic fibrotic lung disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01154998

Contact: Felix Chua, MBBS 0208 725 1261

United Kingdom
St George's Hospital Not yet recruiting
London, United Kingdom, SW17 0QT
Sponsors and Collaborators
St George's Healthcare NHS Trust
  More Information

Responsible Party: Dr Felix Chua, St George's Healthcare NHS Trust Identifier: NCT01154998     History of Changes
Other Study ID Numbers: 10/H1102/46
Study First Received: June 30, 2010
Last Updated: June 30, 2010

Keywords provided by St George's Healthcare NHS Trust:
non-specific interstitial pneumonia

Additional relevant MeSH terms:
Lung Diseases
Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Idiopathic Interstitial Pneumonias
Lung Diseases, Interstitial
Heart Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Cardiovascular Diseases processed this record on April 28, 2017